EPRX
Price
$5.71
Change
-$0.03 (-0.52%)
Updated
Sep 29, 01:54 PM (EDT)
Capitalization
289.94M
37 days until earnings call
NAGE
Price
$9.91
Change
+$0.15 (+1.54%)
Updated
Sep 29, 02:13 PM (EDT)
Capitalization
778.39M
30 days until earnings call
Interact to see
Advertisement

EPRX vs NAGE

Header iconEPRX vs NAGE Comparison
Open Charts EPRX vs NAGEBanner chart's image
Eupraxia Pharmaceuticals
Price$5.71
Change-$0.03 (-0.52%)
Volume$100
Capitalization289.94M
Niagen Bioscience
Price$9.91
Change+$0.15 (+1.54%)
Volume$1.07K
Capitalization778.39M
EPRX vs NAGE Comparison Chart in %
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. NAGE commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a StrongBuy and NAGE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (EPRX: $5.74 vs. NAGE: $9.76)
Brand notoriety: EPRX and NAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 106% vs. NAGE: 58%
Market capitalization -- EPRX: $289.94M vs. NAGE: $778.39M
EPRX [@Biotechnology] is valued at $289.94M. NAGE’s [@Biotechnology] market capitalization is $778.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileNAGE’s FA Score has 1 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • NAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, NAGE is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 7 TA indicator(s) are bullish while NAGE’s TA Score has 6 bullish TA indicator(s).

  • EPRX’s TA Score: 7 bullish, 3 bearish.
  • NAGE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, EPRX is a better buy in the short-term than NAGE.

Price Growth

EPRX (@Biotechnology) experienced а -3.69% price change this week, while NAGE (@Biotechnology) price change was -1.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +11.11%, and the average quarterly price growth was +59.53%.

Reported Earning Dates

EPRX is expected to report earnings on Nov 05, 2025.

NAGE is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAGE($778M) has a higher market cap than EPRX($290M). NAGE (83.977) and EPRX (81.073) have similar YTD gains . NAGE has higher annual earnings (EBITDA): 18.1M vs. EPRX (-28.83M). NAGE has more cash in the bank: 60.3M vs. EPRX (19.8M). EPRX has less debt than NAGE: EPRX (35.1K) vs NAGE (3.29M). NAGE has higher revenues than EPRX: NAGE (116M) vs EPRX (0).
EPRXNAGEEPRX / NAGE
Capitalization290M778M37%
EBITDA-28.83M18.1M-159%
Gain YTD81.07383.97797%
P/E RatioN/A44.36-
Revenue0116M-
Total Cash19.8M60.3M33%
Total Debt35.1K3.29M1%
FUNDAMENTALS RATINGS
NAGE: Fundamental Ratings
NAGE
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
25
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPRXNAGE
RSI
ODDS (%)
Bearish Trend 4 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
69%
MACD
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
42%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGPKY5.800.06
+1.05%
PGE Polska Energetyczna SA
MQBKY142.551.28
+0.91%
Macquarie Group, Ltd.
INTI0.06N/A
N/A
Inhibitor Therapeutics Inc.
KLRGF18.35N/A
N/A
Keller Group Plc
LVPA1.01N/A
N/A
Lvpai Group Limited

EPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with NAGE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then NAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
-0.35%
NAGE - EPRX
34%
Loosely correlated
+3.72%
ETNB - EPRX
29%
Poorly correlated
N/A
ACAD - EPRX
28%
Poorly correlated
-0.75%
IRON - EPRX
26%
Poorly correlated
+4.88%
IOVA - EPRX
26%
Poorly correlated
+4.46%
More

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with IRON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
+3.72%
IRON - NAGE
45%
Loosely correlated
+4.88%
MDGL - NAGE
44%
Loosely correlated
+0.29%
AXON - NAGE
43%
Loosely correlated
-0.46%
AMRN - NAGE
35%
Loosely correlated
+3.56%
CYTK - NAGE
35%
Loosely correlated
+5.37%
More